Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHRONIC LYMPHOCYTIC B-LEUKEMIA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05694312
What this trial is testing

Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL

Who this might be right for
Autoimmune Hemolytic AnemiaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 45
Not applicableEnded earlyNCT03436771
What this trial is testing

Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product

Who this might be right for
Non Hodgkin LymphomaMultiple MyelomaChronic Lymphocytic Leukemia+3 more
Juno Therapeutics, a Subsidiary of Celgene 4
Testing effectiveness (Phase 2)Study completedNCT00378534
What this trial is testing

Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaChronic Lymphocytic Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 116
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Early research (Phase 1)Study completedNCT00871663
What this trial is testing

Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6)

Who this might be right for
Solid TumorsLymphoma, Non-HodgkinMultiple Myeloma+1 more
Merck Sharp & Dohme LLC 123
Large-scale testing (Phase 3)Study completedNCT00003204
What this trial is testing

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Stage III Grade 1 Follicular LymphomaStage III Grade 2 Follicular LymphomaStage III Grade 3 Follicular Lymphoma+5 more
National Cancer Institute (NCI) 515
Large-scale testing (Phase 3)Study completedNCT00003414
What this trial is testing

Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

Who this might be right for
Graft Versus Host DiseaseLymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Large-scale testing (Phase 3)UnknownNCT00003337
What this trial is testing

Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Gilead Sciences 100
Testing effectiveness (Phase 2)Looking for participantsNCT04908228
What this trial is testing

Fixed-duration Therapy With Ibrutinib and Obinutuzumab (GA-101) in Treatment-naïve Patients With CLL

Who this might be right for
Chronic Lymphocytic Leukemia
Paolo Ghia 53
Testing effectiveness (Phase 2)Study completedNCT02500407
What this trial is testing

A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Lymphocytic Leukemia, ChronicLymphoma, Non Hodgkin
Genentech, Inc. 713
Testing effectiveness (Phase 2)WithdrawnNCT00621036
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+1 more
University of Texas Southwestern Medical Center
Large-scale testing (Phase 3)Study completedNCT04285567
What this trial is testing

Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
Hoffmann-La Roche 166
Early research (Phase 1)Study completedNCT02890758
What this trial is testing

Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Lymphoblastic Leukemia+11 more
Brenda Cooper, MD 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT05677919
What this trial is testing

Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Mayo Clinic 72
Early research (Phase 1)Ended earlyNCT05153330
What this trial is testing

Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Mixed-Phenotype Leukemia+12 more
Biomea Fusion Inc. 55
Early research (Phase 1)Study completedNCT01164163
What this trial is testing

INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+2 more
Children's Oncology Group 49
Testing effectiveness (Phase 2)Study completedNCT00546793
What this trial is testing

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

Who this might be right for
NHLLymphoma, Non-HodgkinLymphoma, B-Cell+15 more
Gilead Sciences 32
Early research (Phase 1)Study completedNCT00049699
What this trial is testing

VNP40101M in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Vion Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01750567
What this trial is testing

A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL

Who this might be right for
Relapsed Chronic Lymphocytic Leukemia
University of Michigan Rogel Cancer Center 37
Very early researchLooking for participantsNCT07428707
What this trial is testing

Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
National Heart, Lung, and Blood Institute (NHLBI) 30
Next Page